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Abstract 
A 60-year-old lady presented to us with a right upper abdominal mass. With a clinical 
diagnosis of liver tumor, she was evaluated with abdominal CT, MRI, nuclear scan, tumor 
markers, USG guided FNAC and other baseline investigations. On evaluation she had a 
massive right lobe tumor crossing the midline. In view of the ambiguous diagnosis she 
was subjected to laparotomy where the lesion was judged unresectable and a biopsy 
was taken. Histopathological examination showed the rare pathology of primary 
fibrosarcoma of the liver with features of homogeneous, spindle-shaped cells with 
abundant collagen fibers showing a classic herringbone pattern. Tissue samples were 
then sent to another referral cancer hospital for immunohistochemistry and 
immunoreactive vimentin was found in the tumor cells. Electron microscopically, the 
tumor cells were rich in rough endoplasmic reticulum without a basement membrane, 
and were surrounded by large amounts of collagen fibers. The fibroblastic character of 
the tumor cells was suggested by light and electron microscopy. 
 
Case Report 
A 60-year-old lady presented to our sister department of Medical Gastroenterology at a tertiary 
health care institute with a history of an increasing mass in the right upper abdomen of one and a half 
year duration. She also had a history of weight loss due to early satiety and decreasing appetite. She had 
been evaluated with abdominal CECT 14 months before by some local doctor which had shown a mass 
lesion in the right lobe of the liver. She had not seen any doctor subsequently for further workup.  
General physical examination revealed that the patient was cachectic with mild pallor. All her 
systemic examinations were normal except a big nodular mass in the right hypochondrium merging 
with the liver. The Department of Medical Gastroenterology considered her for a repeat workup, with 
abdominal MRI, RBC trigged nuclear scan of the liver, serum tumor markers and routine base  
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investigations. MRI showed a nodular mass lesion arising from the right lobe of the liver, crossing 
towards the left lobe with involvement of the right portal vein, with areas of cystic changes and 
hemorrhage within the lesion (fig. 1). Nuclear scan subsequently ruled out the possibility of a vascular 
origin of the tumor. Her tumor markers, including α-fetoprotein, CEA, CA 19-9 and βHCG, were all 
within normal limits. She was also subjected to upper and lower gastrointestinal endoscopy to rule out 
any occult primary lesion in the gastrointestinal tract. Routine laboratory investigations including liver 
function tests, hemogram, kidney function, chest X-ray and ECG were within fairly normal limits, her 
coagulogram revealing PT elevated by 3 s. Serology was negative for hepatitis B and C. She was also 
subjected to USG guided FNAC which was inconclusive and revealed only blood cells. 
After complete workup with a tentative diagnosis of fibrolamellar hepatocellular carcinoma the 
patient was referred to our department for surgical intervention. She was offered a diagnostic and if 
possible curative laparotomy after repeat imaging (abdominal CECT) as she had again lapsed a period 
of 3–4 months after her workup. Due to monitoring constraints, her attenders did not agree to get an 
abdominal CT but were ready for any possible surgical intervention with the minimum of a biopsy to 
plan further treatment. 
On exploration the patient was found to have nodular bilobular disease occupying almost all of the 
liver. These nodules were grossly greyish white in appearance (fig. 2, fig. 3). There were areas of boggy 
swelling in between firm nodules predominantly on the inferior surface of liver suggestive of bleeding 
within the tumor on aspiration. The lesion involving both lobes of the liver was too big and multicentric 
for any resectional procedure and so a biopsy from the lesion was taken safely. Her postoperative period 
was uneventful. After getting her histopathological report the patient was referred to a medical 
oncologist for further treatment. 
The histopathology report revealed a rare pathology of primary fibrosarcoma of the liver. This is the 
first case of fibrosarcoma of the liver reported at our institute. On light microscopy the tumor revealed 
homogeneous, spindle-shaped cells with abundant collagen fibers showing a classic herringbone pattern 
(fig. 4). Tissue samples were then sent to another referral cancer hospital for immunohistochemistry 
where immunoreactive vimentin was found in the tumor cells. Electron microscopically, the tumor cells 
were rich in rough endoplasmic reticulum without a basement membrane and were surrounded by large 
amounts of collagen fibers. The fibroblastic character of the tumor cells was suggested by light and 
electron microscopy. 
Discussion 
Sarcomatous tumors commonly occur in the retroperitoneum of the abdomen. The 
various types of sarcomas include angiosarcomas, liomyosarcomas, liposarcomas and 
fibrosarcomas. The purpose of this case report is to share information on a rare tumor of 
the liver, a primary fibrosarcoma, as up to the late seventies the literature about this entity 
was restricted to autopsy diagnosis [1]. To our knowledge there are case reports from 
various parts of the world [2, 3], but there are no series of cases of primary fibrosarcoma 
of the liver. Etiologically exposure to cadmium has been linked to carcinogenesis of this 
disease in animal models [4]. Poggio et al. described a series of 20 cases of sarcomatous 
tumors of the liver, of which angiosarcoma was the commonest, and concluded that 
primary treatment is surgery with survival depending on the degree of differentiation [5]. 
From the available literature, primary treatment to be considered for fibrosarcoma of 
the liver is surgery with curative intent. In a recent article from Sloan-Kettering Cancer 
Center, between 1981 and 2004 they identified only 30 cases of primary liver sarcomas of 
which most cases (10) were hemangioendotheliomas and only 3 were diagnosed to be 
primary fibrosarcoma. Only 11 of these patients underwent R0 resection and this group of 
resected tumors had a 5-year survival rate of 65% [6]. Unfortunately our patient presented 
quite late in the course of disease even if we consider her first CT scan done one and a half 
year back. Clinically these patients present with pain and constitutional symptoms. There 
is a report of one patient with primary fibrosarcoma presenting with frequent episodes of  
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hypoglycemia, where insulin-like growth factor II was intensely stained in the Golgi area 
of the tumor cells, suggesting its role in the mechanism of hypoglycemia [7]. 
On histopathological examination these neoplasms show typical light microscopic 
features like that of malignant rhabdoid tumor with filamentous cytoplasmic inclusions 
(fig. 4), and on electron microscopic examination show staining for both cytokeratin and 
vimentin by immunohistochemistry [8]. After making a diagnosis of primary 
fibrosarcoma of the liver at an inoperable stage, an extensive review of the literature 
regarding the role of other treatment modalities was done which was not encouraging 
[5, 8]. Though few reports recommend chemotherapy [9] in liver metastasis of 
retroperitoneal fibrosarcoma consisting of cyclophosphamide, vincristine, farmorubicin, 
and dacarbazine, there is no definite role as treatment for primary lesion of liver. Overall 
the prognosis reported by most of the authors is dismal [1–3, 10].  
We conclude by passing on the message that this rare entity does exist and is an area 
for workup to make guidelines for management of such tumors. This may be one of the 
few reported cases of primary hepatic fibrosarcoma confirmed by immunohistochemistry 
and electron microscopy. 
Fig. 1. MRI of the lesion. 
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Fig. 2. Typically greyish white nodular lesion found on surgery. 
 
 
 
Fig. 3. Largest nodule involving the right lobe of the liver (operative picture). 
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Fig. 4. Typical features of liver fibrosarcoma. 
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